NICE NG89 recommendations for extended pharmacological thromboprophylaxis - is it justified and is it cost effective: a rebuttal from the British Society for Haematology.

Authors :: Lester W
Gomez K
Shapiro S
Dabhi K
Laffan M
Source :: British journal of haematology [Br J Haematol] 2019 Sep; Vol. 186 (5), pp. 790-791. Date of Electronic Publication: 2019 Jun 05.
Publication Year :: 2019

Subjects :: Anticoagulants economics
Cost-Benefit Analysis
Humans
United Kingdom
Venous Thromboembolism prevention & control
Anticoagulants therapeutic use

Full Text Access

Tools